$PRCT — let me walk you through this one because the setup is clean. The company: PROCEPT BioRobotics. Makes the Aquablation robot for enlarged prostate surgery. 65% gross margins. 20% revenue growth last quarter. $249M cash. ~50% of men over 50 have BPH — the market is massive and barely penetrated. New CEO reset the business in Q4, eliminated discount programs that were distorting revenue, took the one-time hit — Q1 bounced back immediately. The insider signal: Director Antal Rohit Desai dropped $10.5M in open-market buys at $23–$25 in March. Three separate transactions. 426K shares accumulated. 89% of the float held by institutions. The chart: 8H is forming a textbook cup. The 200 SMA traces the arc perfectly. Cup lip at $30 — price is testing it right now. Measured move off a breakout = ~$58. Options tape this week: three Jun 18 call sweeps/splits buying $27.5 and $30 strikes. Someone is positioning for the breakout before June 18. 🐂 $30 closes on volume = cup confirmed, $36–$38 200 SMA target, measured move to ~$58 over time 🐻 $30 rejects = $26.44 then $23.50, need more base-building, cup lip holds as resistance ⚠️ $10.5M insider buy at the exact bottom. Jun call sweeps stacking right at the breakout level. 8H 200 SMA cup-and-handle. Is $PRCT the cleanest surgical robotics setup on the board right now? 👇 #PRCT #PROCEPTBioRobotics #Aquablation #SurgicalRobotics #MedTech #OptionsFlow #TechnicalAnalysis #hovdid

Some of the most important work in healthcare happens behind the scenes. Honored to close out the year working with Procept BioRobotics on an internal training video focused on physician engagement. Huge respect to medical reps and staff everywhere—your quiet, consistent work makes better patient outcomes possible every day. Grateful to be part of it. Thank you Mike Palahach, Park Dietz, Courtney Hunter, Charlie Wiggins, Maria Andahazy, Katie Avers & Kashilia Young #MedReps #BehindTheScenes #MedTech #PhysicianEngagement #ProceptBioRobotics #Urology #PatientFirst

psyさんが発信されて皆さんご存知のPROCEPT BioRobotics。 前立腺肥大症のAquablation therapy は、低侵襲で日帰り手術が可能な点など、現在の医療ニーズに合った治療法です。医療費の削減や、医師にとって操作しやすい点も大きな特長です。これは前立腺肥大症治療の主流になります。3Dマトリックスとの協業も楽しみ。英国の病院での記事です。 記事概要 英国 Frimley Park Hospital 1日に12件の施術を実施し記録を更新。 11患者が数時間で退院 → 最小限の副作用・早い回復が期待される Frimley Health はイングランドで最初にこの治療を導入している → 既に 500人以上の患者に適用した実績あり 記事にはPROCEPT BioRoboticsの名前ないんです？？ #BPH #PROCEPTBioRobotics #Aquablation #3Dmatrix independent.co.uk/news/healt…

Game changer同士の相性ばつぐん！ 前立腺肥大BPHの手術はロボット手術Aquablation RADA16が標準になります。 高齢化で前立腺肥大症BPH患者が増え、市場拡大が続く中、Procept Biorobotics の Aquablation therapy は、 ・前立腺サイズを問わず安定した切除 ・非熱的で合併症が少ない ・習熟が容易で普及しやすい　本当です。 といった特長から、次世代の主流術式になる可能性が高いと考えています。 一方で課題は術後の*️⃣カテーテル圧迫止血。ここで注目されるのが 3Dマトリックスの RADA16。 水環境でも安定してゲル膜を形成し、Aquablation との相性が非常に良い“非熱的止血材”です。 現在、臨床試験 NCT06948331 でその有用性を検証中。 Aquablation の普及とともに、RADA16 が大きく存在感を増すと期待しています。 *️⃣手術後にカテーテルが、あそこに突っ込まれているのは本当に辛いんですよ。経験した男性の皆さんならわかると思います。😭　RADA16は辛いテネスムス症状を軽減する可能性があります。 #前立腺肥大症 #BPH #ProceptBiorobotics #Aquablation #3Dmatrix #3Dマトリックス #RADA16 #Purastat #Purashield #テネスムス軽減

PROCEPT BioRobotics announces Q2 2025 results Q2 2025 Highlights: • Total revenue of $79.2 million, up 48% YoY • International revenue of $9.6 million, up 69% YoY • Achieved gross margins of 65% in the second quarter • Increased fiscal year 2025 total revenue guidance to $325.5 million, an increase of 45% compared to the prior year period in 2024 • Appointed Larry Wood as Chief Executive Officer, effective September 2, 2025, who brings 40 years of leadership experience in the global medical technology industry Thank you for your continued support as we advance patient care through transformative solutions in urology! Read the full press release here bit.ly/46LoGp1 #PROCEPTBioRobotics #AquablationTherapy #FinancialResults #HealthcareInnovation

This Independence Day, we celebrate the freedom of our nation and the freedom we provide to men through innovative treatments like Aquablation® therapy. By offering relief from BPH symptoms, we're helping men reclaim their quality of life and enjoy greater independence every day. Happy 4th of July from all of us at PROCEPT BioRobotics®! #IndependenceDay #PROCEPTBioRobotics

On June 2, 2025 at 7:30 AM ET/PT on Lifetime, Aquablation® therapy will be featured in an upcoming segment on Health Uncensored with Dr. Drew on the LifeTime Network. The segment will explore how this robotic-assisted, minimally invasive treatment is advancing the standard of care for BPH — delivering long-lasting relief with low rates of side effects.(1,2) If you’re a urologist or healthcare provider interested in surgical innovation and patient-centered outcomes, this is a conversation you won’t want to miss. #AquablationTherapy #BPH #UrologyInnovation #ProceptBioRobotics #MensHealthMonth 1. Gilling PJ, et al. Can J Urol. 2022 2. Bhojani N, et al. J Urol. 2023 Safety Information: bit.ly/48PsIM6

Record-breaking Friday at Advent Health Winter Garden! We successfully completed 9 surgical cases—including 6 robotic Aquablation procedures using the Hydros system with Strauss MCP for BPH, and 2 robotic-assisted microsurgical varicocelectomies for male infertility. Truly honored to host the legendary Dr. Stephen Yu and the brilliant Dr. Beibei Oelrich as they observed a few of our advanced prostate Aquablation cases focused on precision, ejaculatory preservation, and crystal-clear outcomes. Big shoutout to our amazing OR, pre-op, post-op, anesthesia, and admin teams—none of this would be possible without you. Let’s keep pushing the boundaries of men’s health! #Aquablation #StraussMCP #RoboticSurgery #Varicocelectomy #MensHealth #UrologyInnovation #AvantUrology #ProstateHealth #BPH #InfertilityCare #HydrosSystem #Teamwork #enlargedprostate #bph #varicocele #maleinfertility #fertility @proceptbiorobotics @intuitivesurgical #davincirobot #davincisurgery

Behind every innovation, there are passionate people making a difference – at #ProceptBioRobotics. Matt Young, VP of Product Management, shares: “What I really love about this company is the people I get to work with every day to bring innovative technology that impacts our healthcare providers and, ultimately, improves the lives of the men we serve.” Listen to hear more from Matt and discover what drives his passion at PROCEPT BioRobotics®! #PROCEPT #BPH #MENSHEALTH

Golden Trifecta Friday: All-Out Robotic Aquablation Day Last Friday was a full-force robotic surgery day with 4 Hydros Robotic Aquablation cases back-to-back! We are laser-focused on delivering the Golden Trifecta for every patient: 1.Preserved – Verumontanum preservation using the Hydros AI Butterfly Cut 2.Restored – Creating a wide-open prostatic channel for amazing urinary flow 3.Clear – Achieving crystal clear urine post-op with the Strauss MCP (Meticulous Focal Cautery Protocol): no traction, no bladder irrigation. All patients were discharged home in under 1 hour after surgery. No bleeding. Just clear results. This is the future of BPH care—preserve function, restore flow, and keep it clear. #RoboticUrology #HydrosAquablation #StraussMCP #GoldenTrifecta #BPH #UrologyInnovation #AvantUrology #enlargedprostate #weakstream #weakflow #aquablation @proceptbiorobotics @strausssurgical

PROCEPT BioRobotics announces Q1 2025 results Q1 2025 Highlights: Total revenue of $69.2 million, up 55% YoY International revenue of $8.9 million, up 104% YoY Achieved gross margins of 64% in the first quarter Increased 2025 revenue guidance to $323M ( 44% y/y) Thank you for your continued support as we advance patient care through transformative solutions in urology! bit.ly/3YNt81A #PROCEPTBioRobotics #AquablationTherapy #FinancialResults #HealthcareInnovation

A day in Life of a Urologist: Friday Wrapped up a record 11 cases by 6:30PM — including 7 Robotic Prostate Aquablation with Strauss Fluff MCP procedures, 1 robotic varicocelectomy, and 3 urgent add-ons. Grateful to have hosted the incredible Dr. Fawaz Ashouri and Dr. James Fogarty — true leaders in our field. None of this happens without the Rockstar team at AdventHealth Winter Garden — pre-op, OR, post-op, anesthesia, and admin — you all went above and beyond. Thank you for making this possible. #UrologyLife #RoboticSurgery #Aquablation #Varicocelectomy #ORTeam #AdventHealth #Gratitude #SurgicalLife #MensHealth #FridayWins #bph #prostateenlargement #weakstream #nocturia #frequency #urgency #aquablation #prostateaquablation @proceptbiorobotics @strausssurgical #hydrosaquablation @figs @on #mcp #roboticmicrosurgery #varicocelectomy #varicocele @intuitivesurgical @adventhealth @adventhealthcfl @louisvuitton @bmw @bmwusa

Sometimes you just need the right tools for the job. Had a case today of a patient who had a Urolift procedure a few years ago for an enlarged prostate. However, his weak stream, frequency and getting up at night to pee, started to come back. One treatment option is Hydros Robotic Aquablation with the Strauss “fluff” MCP (meticulous cautery protocol). The Strauss loop allows for the efficient and safe removal of the urolift clips without any loop damage. The Strauss loop is strong enough not to break, during the removal of the urolift clips. Effective “fluff” cautery achieves hemostasis so that the patient can be sent home less than an hour after surgery with no traction and no bladder irrigation. The Hydros Aquablation “butterfly” cut allows for the best chance of preserving the ejaculation mechanism. This combination of technologies really optimizes outcomes. A huge shout out to the great Dr. Robert S. Bradford (AUI, Solaris Health) for visiting us today from Tallahassee and observing a few Hydros cases with us. #bph #prostateenlargement #weakstream #nocturia #frequency #urgency #aquablation #prostateaquablation @proceptbiorobotics @strausssurgical @teleflex #urolift #hydrosaquablation @figs @on @solarishealth #mcp

Amazing day today! Honored to give the opening lecture for the Southeastern section of the American Urology Association (SESAUA) Annual Meeting at the Grand Hyatt Nashville today! My talk was on the management of chronic testicular and groin pain. It’s been 15 years of my life’s work and a topic I am immensely passionate about. This is truly an example of the development of bench research all the way to clinical application. I completed a study 15 years ago identifying specific nerves that may cause this pain and developed some targeted surgical techniques to treat this condition: 1) Office-based Targeted denervation of the spermatic cord (TDSC) & 2) Office-based Targeted peri-spermatic cord & ilioinguinal cryoablation (TPSC). We have completed over 3000 TDSC procedures and over 1500 TPSC procedures now. Overall success rates are: 86% for TDSC & 78% for TPSC. It is a very difficult condition for patients who endure this pain and for urologists to treat. We have helped thousands of patients, but we have also failed to help some patients. Being able to present today, being part of the AUA guidelines committee for some new guidelines for pelvic pain that will be coming out in a few months, and being part of an AUA pelvic pain course at this year’s annual meeting are all a dream come true for me. I really just want to help men with this condition and contribute in a meaningful way. We are always looking for ways to improve our outcomes. Got to check out some cool new technology from @bostonscientific and @emanoflow - just had a bit of performance anxiety for my flow test !! #neverstopdreaming #neverstoplearning #technologyrules #testicularpain #chronictesticularpain #chronicorchialgia #chronicpain @proceptbiorobotics @rocamed @elestalaser @adidas @spiritairlines @hyatt @grandhyattnashville @nashvilletn @hugobossmillenia @boss #sesaua25 @southeasternaua @amerurological #manvsprostate

We were thrilled to host our second Prostate Innovation Forum in Dallas, where experts came together to explore how Aquablation® therapy is redefining the standard of care for BPH. Thank you, Amy Fischer; #GeraldPark, #ChristopherKelly, #KevinZorn, #BrianHelfand, #LewisKriteman,MD and #AlexHughes, NP for sharing your valuable insights on Aquablation therapy with surgeons from across the country! #AquablationTherapy #BPH #ProceptBioRobotics

A big thank you to Dr. Brian Helfand for sharing your expertise on how Aquablation® therapy is driving value across the healthcare continuum at our PROCEPT BioRobotics® Prostate Innovation Forum in Dallas! This event brings surgeons together from across the country to explore how Aquablation therapy is rapidly becoming the standard of care for BPH. By advancing innovation and prioritizing patient outcomes, we’re shaping the future of BPH treatment. Here’s to pushing boundaries and improving lives! #AquablationTherapy #BPH #ProceptBioRobotics #PatientCare

PROCEPT BioRobotics announces Q4 2024 results Q4 2024 Highlights: • Total revenue of $68.2 million, up 57% YoY • Sold 60 robotic systems in the U.S. • Achieved gross margins of 64% in the fourth quarter Thank you for your continued support as we advance patient care through transformative solutions in urology! bit.ly/3XiZUqL #PROCEPTBioRobotics #AquablationTherapy #FinancialResults #HealthcareInnovation

Join us at the Florida Urological Society in Orlando, FL, from December 13-14, 2024! Discover the HYDROS™ Robotic System, the next-generation, AI-powered robotic platform for Aquablation® therapy. The HYDROS System features FirstAssist AI™ treatment planning, advanced image guidance, robotic resection, and a streamlined workflow. A perfect opportunity to learn more about the HYDROS System designed to improve efficiency, enhance surgeon and staff experience, and deliver an accurate and consistent treatment plan for better clinical outcomes. Learn more about the HYDROS System on our new PROCEPT BioRobotics website: bit.ly/3AsgxYA #HYDROS #AquablationTherapy #PROCEPTBioRobotics Safety information bit.ly/3TChpkT

NASDAQ welcomed PROCEPT BioRobotics® back to New York City to celebrate being one of the world’s fastest-growing surgical robotics companies! We're thrilled to see Aquablation® therapy rapidly becoming the standard of care for BPH, and revolutionizing treatment for patients. 🚀 Q3 2024 Highlights for PROCEPT BioRobotics 🚀 It’s been an exciting quarter as we continue to advance in the field of BPH treatment! Here are some standout achievements from Q3: • Strong momentum accelerating adoption, reflected in our Q3 earnings • Launch of the HYDROS™ Robotic System, the next generation surgical platform • Celebrated 3-year IPO anniversary • Aggregate gross proceeds of approximately $175 million in capital to fuel strategic growth Here’s to more milestones and making a meaningful impact in the urology space! #PROCEPTBioRobotics #NASDAQ #Aquablation #BPH #SurgicalInnovation #Movember bit.ly/3TChpkT

🚀 PROCEPT BioRobotics announces Q3 2024 results, increases 2024 revenue and adjusted EBITDA guidance 📈 Q3 2024 Highlights: • Total revenue of $58.4 million, up 66% YoY • Sold 45 robotic systems in the U.S. • U.S. handpiece and consumables revenue of $29.6M, a 74% increase YoY • Achieved record gross margins of 63.2% in the third quarter • Received FDA clearance and launched the HYDROS™ Robotic System in August Thank you for your continued support as we advance patient care through transformative solutions in urology! bit.ly/3AhWdcI #PROCEPTBioRobotics #AquablationTherapy #FinancialResults #HealthcareInnovation